68 related articles for article (PubMed ID: 24940888)
1. [Reasons for antiretroviral treatment change in HIV+ patients in Spain in 2010-2011. SWITCH AUDIT Study].
Pedrol E; Viciana P; Arranz A; Pasquau J; Deig E; Tasias M;
Rev Esp Quimioter; 2014 Jun; 27(2):93-7. PubMed ID: 24940888
[TBL] [Abstract][Full Text] [Related]
2. [Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection].
Blanes M; Belinchón I; Merino E; Portilla J; Sánchez-Payá J; Betlloch I
Actas Dermosifiliogr; 2010 Oct; 101(8):702-9. PubMed ID: 20965013
[TBL] [Abstract][Full Text] [Related]
3. Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
Burgos J; Crespo M; Falcó V; Curran A; Navarro J; Imaz A; Domingo P; Podzamczer D; Mateo MG; Villar S; Van den Eynde E; Ribera E; Pahissa A
J Antimicrob Chemother; 2012 Oct; 67(10):2479-86. PubMed ID: 22729925
[TBL] [Abstract][Full Text] [Related]
4. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.
Cicconi P; Cozzi-Lepri A; Castagna A; Trecarichi EM; Antinori A; Gatti F; Cassola G; Sighinolfi L; Castelli P; d'Arminio Monforte A;
HIV Med; 2010 Feb; 11(2):104-13. PubMed ID: 19732176
[TBL] [Abstract][Full Text] [Related]
5. Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010.
Jarrin I; Hernández-Novoa B; Alejos B; Riera M; Navarro G; Bernardino JI; Rivero M; del Amo J; Moreno S;
Antivir Ther; 2013; 18(2):161-70. PubMed ID: 22997147
[TBL] [Abstract][Full Text] [Related]
6. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
7. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
9. Relevant gender differences in epidemiological profile, exposure to first antiretroviral regimen and survival in the Spanish AIDS Research Network Cohort.
Pérez-Elías MJ; Muriel A; Moreno A; Martinez-Colubi M; Iribarren JA; Masiá M; Blanco JR; Palacios R; Del Romero J; Pérez DG; Hernando V;
Antivir Ther; 2014; 19(4):375-85. PubMed ID: 24304821
[TBL] [Abstract][Full Text] [Related]
10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective epidemiological study on the durability of the treatment of HIV infection or AIDS in Spain].
Arribas López JR; Sanz Baena S; Hernández Albujar S; Lorenzo Hernández A; Montes Ramiréz ML; Palacios Muñoz R; Márquez Solero M; Santos González J; Ocampo Hermida A; Miralles Alvarez C; López Aldeguer J; Salavert Lletí M; Tordera Higón P; Santamaría Jáuregui JM; Teira Cobo RM; Moreno Guillén S; Moreno Zamora A; Gatell Artigas JM; Mallotas Masferrer J; Callau Cabrera P; Gonzáles de Suso MT; Costa Cerdá A; Cepeda Gonzáles C; Pulido Ortega F; Condes Moreno E; Barros Aguado C; del Llano Señarís J; Coduras A; Olivia J; Burgos Ramírez A; González-Lahoz J; Díaz B;
Med Clin (Barc); 2002 Nov; 119(19):721-4. PubMed ID: 12487966
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
[TBL] [Abstract][Full Text] [Related]
13. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in HIV-infected patients: prevalence and related factors.
Jericó C; Knobel H; Montero M; Sorli ML; Guelar A; Gimeno JL; Saballs P; López-Colomés JL; Pedro-Botet J
Am J Hypertens; 2005 Nov; 18(11):1396-401. PubMed ID: 16280270
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.
Crespo M; Ribera E; Suárez-Lozano I; Domingo P; Pedrol E; López-Aldeguer J; Muñoz A; Viladés C; Sánchez T; Viciana P; Teira R; García-Alcalde ML; Vergara A; Lozano F; Galindo MJ; Cosin J; Roca B; Terrón A; Geijo P; Vidal F; Garrido M;
J Antimicrob Chemother; 2009 Jan; 63(1):189-96. PubMed ID: 18988678
[TBL] [Abstract][Full Text] [Related]
16. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
[TBL] [Abstract][Full Text] [Related]
17. Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons.
Maiese EM; Johnson PT; Bancroft T; Goolsby Hunter A; Wu AW
Curr Med Res Opin; 2016 Dec; 32(12):2039-2046. PubMed ID: 27552553
[TBL] [Abstract][Full Text] [Related]
18. Reasons for switching ART: Comparison of data collected in 2012-2013 and 2014-2015 in Florence, Italy.
Fusco FM; Burla MC; Degli Esposti A; Pierotti P; Rabatti L; Vichi F
Int J STD AIDS; 2018 Mar; 29(4):392-395. PubMed ID: 28853677
[TBL] [Abstract][Full Text] [Related]
19. An audit of antiretroviral medication offered to patients with HIV attending a district general hospital for outpatient care.
Ivens D; Brook G
Int J STD AIDS; 2000 Mar; 11(3):193-5. PubMed ID: 10726946
[TBL] [Abstract][Full Text] [Related]
20. Triple-class HIV antiretroviral therapy failure in an Australian primary care setting.
Bloch M; Farris M; Tilden D; Gowers A; Cunningham N
Sex Health; 2010 Mar; 7(1):17-24. PubMed ID: 20152091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
